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reports

Summary

Characteristic structural features
The HMGRs of different organisms are multimers of a speciesspecific number of identical monomers. High-resolution
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information

Genome sequencing has identified hmgr genes in organisms
from all three domains of life, and over 150 HMGR sequences
are recorded in public databases. Higher animals, archaea,
and eubacteria have only a single hmgr gene, although the
lobster has both a soluble and a membrane-associated
isozyme, both of which are encoded by a single gene). By
contrast, plants, which use both HMGR-dependent and
HMGR-independent pathways to synthesize isoprenoids,

have multiple HMGR isozymes that appear to have arisen by
gene duplication and subsequent sequence divergence [1].
Yeast has two HMGR isozymes derived from two different
genes (hmgr-1 and hmgr-2). Comparison of amino-acid
sequences and phylogenetic analysis reveals two classes of
HMGR, the Class I enzymes of eukaryotes and some archaea
and the Class II enzymes of certain eubacteria and archaea,
suggesting evolutionary divergence between the two classes
(Figure 2, Table 1) [2,3]. The catalytic domain is highly conserved in eukaryotes, but the membrane-anchor domain
(consisting of between two and eight membrane-spanning
helices) is poorly conserved, and the HMGRs of archaea and
of certain eubacteria lack a membrane-anchor domain.

interactions

The human hmgr gene that encodes the single human
HMG-CoA reductase is located on chromosome 5, map
location 5q13.3-5q14, and is over 24.8 kilobases (kb) long.
The 20 exons of the 4,475-nucleotide transcript, which range
in size from 27 to 1,813 base-pairs, encode the membraneanchor domain (exons 2-10), a flexible linker region (exons
10 and 11), and the catalytic domain (exons 11-20) of the
resulting 888-residue polypeptide (Figure 1).

refereed research

Gene organization and evolutionary history

deposited research

The enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase catalyzes the
conversion of HMG-CoA to mevalonate, a four-electron oxidoreduction that is the rate-limiting
step in the synthesis of cholesterol and other isoprenoids. The enzyme is found in eukaryotes and
prokaryotes; and phylogenetic analysis has revealed two classes of HMG-CoA reductase, the
Class I enzymes of eukaryotes and some archaea and the Class II enzymes of eubacteria and
certain other archaea. Three-dimensional structures of the catalytic domain of HMG-CoA
reductases from humans and from the bacterium Pseudomonas mevalonii, in conjunction with sitedirected mutagenesis studies, have revealed details of the mechanism of catalysis. The reaction
catalyzed by human HMG-CoA reductase is a target for anti-hypercholesterolemic drugs (statins),
which are intended to lower cholesterol levels in serum. Eukaryotic forms of the enzyme are
anchored to the endoplasmic reticulum, whereas the prokaryotic enzymes are soluble. Probably
because of its critical role in cellular cholesterol homeostasis, mammalian HMG-CoA reductase is
extensively regulated at the transcriptional, translational, and post-translational levels.
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Figure 1
Schematic representation of the human hmgr gene and the human HMGRH and P. mevalonii HMGRP proteins. (a) The exon-intron structure of the
human hmgr gene, which extends from position 74717172 to position 74741998 of the human genome; positions refer to the Ensembl Transcript ID
for the human hmgr gene (ENST00000287936 [22]). The numbers indicate the start and end of each exon and intron and refer to the position in the
human genome sequence, omitting the first three digits (747); exons are indicated as filled boxes. Exon 1 is an untranslated region (UTR), as are the
last 1,758 nucleotides of exon 20. The exons encoding the membrane-anchor domain, a flexible linker region, and the catalytic domain are indicated
below the gene structure. (b) Human HMGR protein (HMGRH) is comprised of three domains: the membrane-anchor domain, a linker domain, and a
catalytic domain; within the catalytic domain subdomains have been defined. The N domain connects the L domain to the linker domain; the L domain
contains an HMG-CoA binding region; and the S domain functions to bind NADP(H). The cis-loop (indicated by an asterisk), a region present only in
HMGRH but not HMGRP, connects the HMG-CoA-binding region with the NADPH-binding region. (c) The HMGRP protein does not contain the
membrane-anchor domain or the linker domain but has a catalytic domain containing a large domain with an HMG-CoA binding region, and a small,
NAD(H)-binding domain. The active site of HMG-CoA reductase is present at the homodimer interface between one monomer that binds the
nicotinamide dinucleotide and a second monomer that binds HMG-CoA. The numbers underneath the diagrams in (b,c) denote amino acids (in the
single-letter amino-acid code) that are implicated in catalysis; S872 of HMGRH is reversibly phosphorylated. At the extreme carboxyl terminus of each
enzyme is a flap domain (approximately 50 amino acids in HMGRP and 25-30 amino acids in HMGRH) that closes over the active site during catalysis;
the flap domain is indicated by shading in (b,c).

crystal structures have been solved for the Class I human
enzyme (HMGRH) [4,5] and for the Class II enzyme of
Pseudomonas mevalonii (HMGRP) [6,7], including protein
forms bound to either the HMG-CoA substrate or the
coenzyme (NADH or NADPH) or both, or bound to statin
drugs, which are potent competitive inhibitors of HMGR
activity and thus lower cholesterol levels in the blood [8,9].
As reviewed in detail by Istvan [10], structural comparisons
reveal both similarities and significant differences between
the two classes of enzyme. The human HMGR has three
major domains (catalytic, linker and anchor), whereas the
P. mevalonii HMGR has only the catalytic domain (Figure 1).

Both HMGRH and HMGRP have a dimeric active site with
residues contributed by each monomer, and a non-Rossmanntype coenzyme-binding site (a three-dimensional structural
fold that contains a nucleotide-binding motif and is found in
many enzymes that use the dinucleotides NADH and NADPH
for catalysis). The core regions containing the catalytic domains
of the two enzymes have similar folds. Despite differences in
amino-acid sequence and overall architecture, functionally
similar residues participate in the binding of coenzyme A by the
two enzymes, and the position and orientation of four key
catalytic residues (glutamate, lysine, aspartate and histidine) is
conserved in both classes of HMGR.
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P. mevalonii HMGR lacks the cis-loop and the catalytic lysine
is contributed by the monomer that binds the nicotinamide
dinucleotide. HMGRP crystallizes as a trimer of dimers (which
are composed of identical subunits), but HMGRH crystallizes
as a tetramer (of identical units). HMGRP uses NADH as a
coenzyme, whereas HMGRH uses NADPH, but mutation to
alanine of the aspartyl residue of HMGRP that normally blocks
binding of NADPH can allow NADPH to serve - albeit poorly as the coenzyme for HMGRP. A 180o difference in the orientation of the nicotinamide ring of the coenzyme suggests that

interactions

Unlike the central cores, the amino- and carboxy-terminal
regions of the catalytic domains show little similarity between
the human and P. mevalonii HMGR structures. The active site
of HMG-CoA reductase is at the interface of the homodimer
between one monomer that binds the nicotinamide dinucleotide and a second monomer that binds the HMG-CoA. In
human HMGR, the catalytic lysine is found on the monomer
that binds the HMG-CoA and comes from the so-called
cis-loop (a section that connects the HMG-CoA-binding
region with the NADPH-binding region). In contrast, the

refereed research

Figure 2
A phylogenetic tree of HMGRs. The tree includes 98 selected organisms that have hmgr genes; for plants, which have multiple isoforms, only isoform 1 of
each species is included in the tree. Roman numerals indicate the division of the family into two classes [2,3]. Phylogenetic analysis was performed using
aligned amino-acid sequences of HMGR catalytic domains; membrane anchor domains were excluded from analysis. Amino-acid sequence alignments
were generated using ClustalW [23] and the phylogenetic tree constructed with TreeTop [24] using the cluster algorithm with PHYLIP tree-type output.
Full species names and GenBank accession numbers of the sequences used are provided in Table 1.
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Table 1

Table 1 (continued)

Details of the sequences used for the phylogenetic tree in Figure 2

Organism name

Kingdom

Accession
number

Ferroglobus placidus
Archaeoglobus profundus
Archaeoglobus lithotrophicus
Haloferax volcanii
Pyrococcus furiosus
Pyrococcus abyssi
Methanococcus maripaludis
Methanocaldococcus jannaschii
Methanosarcina acetivorans
Methanopyrus kandleri
Sulfolobus tokodaii
Aeropyrum pernix
Methanothermobacter thermautotrophicus
Pyrobaculum aerophilum
Bdellovibrio bacteriovorus
Lactobacillus plantarum
Streptococcus agalactiae
Lactococcus lactis
Vibrio cholerae
Vibrio vulnificus
Vibrio parahaemolyticus
Enterococcus faecalis
Lactobacillus johnsonii
Chloroflexus aurantiacus
Enterococcus faecium
Listeria monocytogenes
Listeria innocua
Streptococcus pneumoniae
Staphylococcus epidermidis
Staphylococcus haemolyticus
Staphylococcus aureus
Streptomyces griseolosporeus
Streptomyces sp.
Streptococcus pyogenes
Streptococcus mutans
Paracoccus zeaxanthinifaciens
Pseudomonas mevalonii
Borrelia burgdorferi
Actinoplanes sp.

Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria
Eubacteria

AJ299206
AJ299205
AJ299203
M83531
AAL81972
AJ248284
CAF29643
AAB98699
AAM06446.
AAM01570
AP000986
AP000062
AAB85068
AAL64009
BX842650
AL935253
CAD47046
AE006387
AAF96622
AAO07090.
BAC62311
AAO81155
AE017204
AJ299212
AF290094
AE017324
CAC96053
AF290098
AF290090
AF290088
AF290086
AB037907
AB015627
AF290096
AAN58647
AJ431696
M24015
AE001169.
AB113568

Organism name*

Mus musculus (mouse)
Mesocricetus auratus (hamster)
Rattus norvegicus (rat)
Homo sapiens (human)
Gallus gallus (chicken)
Xenopus laevis (frog)
Drosophila melanogaster (fruit fly)
Homarus americanus (lobster)
Blatella germanica (cockroach)
Dendroctonus jeffreyi (Jeffrey pine beetle)
Ips pini (bark beetle)
Ips paraconfusus (bark beetle)
Raphanus sativus (radish)
Arabidopsis thaliana (thale-cress)
Oryza sativa (rice)
Lycopersicon esculentum (tomato)
Nicotinia tabacum (tobacco)
Cucumis melo (muskmelon)
Hevea brasiliensis (rubber tree)
Pisum sativum (pea)
Solanum tuberosum (potato)
Tagetes erecta (African marigold)
Catharanthus roseus (Madagascar periwinkle)
Artemisia annua (wormwood)
Gossypium hirsutum (cotton)
Taxus x media (yew)
Andrographis paniculata (Indian herb)
Malus x domestica (apple)
Capsicum annuum (pepper)
Camptotheca acuminata
Saccharomyces cerevisiae (baker’s yeast)
Schizosaccharomyces pombe (fission yeast)
Candida utilis
Trypanosoma cruzi (trypanosome)
Schistosoma mansoni
Leishmania major (trypanosome)
Dictyostelium discoideum
Caenorhabditis elegans
Strongylocentrotus purpuratus (sea urchin)
Dicentrarchus labrax (European sea bass)
Penicillium citrinum
Ustilago maydis
Eremothecium gossypii
Gibberella zeae
Gibberella fujikuroi
Sphaceloma manihoticola
Aspergillus nidulans
Neurospora crassa
Phycomyces blakesleeanus
Archaeoglobus fulgidus
Sulfolobus solfataricus
Oceanobacillus iheyensis
Thermoplasma volcanium
Halobacterium sp
Methanosarcina mazei
Haloarcula hispanica
Thermoplasma acidophilum
Picrophilus torridus
Archaeoglobus veneficus

Kingdom

Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Eukaryote
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea
Archaea

Accession
number
XM_127496
X00494
BC064654
NM_000859
AB109635
M29258
NM_206548
AY292877
X70034
AF159136
AF304440
AF071750
X68651
NM_106299
AF110382
AAL16927
AF004232
AB021862
X54659
AF303583
L01400
AF034760
M96068
AF142473
AF038046
AY277740
AY254389
AY043490
AF110383
U72145
M22002
CAB57937
AB012603
L78791
M27294
AF155593
L19349
NM_066225
NM_214559
AY424801
AB072893
XM_400629
NM_210364
XM_389373
X94307
X94308
EAA60025
XM_324891
X58371
NC_000917
U95360
NC_004193
BAB60335
AAG20075
AAM30031
AF123438
CAC11548
AE017261
AJ299204

*Common names are indicated in parentheses Accession numbers for
each sequence are available from sequence databases accessible through
the National Center for Biotechnology Information [25].

that the stereospecificity of the HMGRH hydrogen transfer is
opposite to that of HMGRP.
Comparisons between the HMGRP and HMGRH structures
reveal an overall similarity in how they bind statins, which
inhibit activity by blocking access of HMG-CoA to the active
site. There is a considerable difference in specific interactions with inhibitor between the two enzymes, however
[8,9], accounting for the almost 104-fold higher Ki values for
inhibition of HMGRP by statin relative to the inhibition of
HMGRH (Ki is the equilibrium constant for an inhibitor
binding to an enzyme). There are significant differences in
the regions of the two proteins that bind statins. In both
enzymes the portion of the statin that resembles HMG (see

Genome Biology 2004, 5:248
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Figure 3) occupies the HMG portion of the HMG-CoAbinding pocket, and the non-polar region partially occupies a
portion of the coenzyme-A-binding site. For HMGRP, this
impairs closure over the active site of the ‘tail’ domain that
contains the catalytic histidine.
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H

OH

Localization and function

SCoA

Stage 3: [Mevaldehyde] + NADPH + H+  Mevalonate + NADP+

Regulation
A highly regulated enzyme, HMGRH is subject to transcriptional, translational, and post-translational control [12] that
can result in changes of over 200-fold in intracellular

Figure 3
Structures of lovastatin, a statin drug that competitively inhibits HMGR,
and of HMG-CoA. It can be seen that the portion of the drug shown here
at the top resembles the HMG portion of HMG-CoA.

levels of the enzyme. The transcription factor sterol regulatory
element-binding protein 2 (SREBP-2) participates in regulating levels of HMGRH mRNA in response to the level of
sterols [13]; the regulatory process is as follows. At the ER
membrane or the nuclear envelope, SREBP-2 binds to
SREBP cleavage activating protein (SCAP) to form a
SCAP-SREBP complex that functions as a sterol sensor. The
proteins Insig-1 and Insig-2 bind to SCAP when cellular
cholesterol levels are high and prevent movement of the
SCAP-SREBP complex from the ER to the Golgi. In cells
depleted of cholesterol, Insig-1 and Insig-2 allow activation
of the SCAP-SREBP complex and its translocation to the
Golgi, where SREBP is cleaved at two sites. Cleavage releases
the amino-terminal basic helix-loop-helix (bHLH)
domain, which enters the nucleus, where it functions as a
transcription factor that recognizes non-palindromic
decanucleotide sequences of DNA called sterol-regulatory
elements (SREs). Binding of the bHLH domain of SREBP to
an SRE promotes transcription of the hmgr gene.
Degradation of HMGRH involves its transmembrane regions
[14]: removal of two or more transmembrane regions abolishes
the acceleration of HMGRH degradation that occurs under
certain conditions [12,15]: degradation is induced by a
non-sterol, mevalonate-derived metabolite alone or by a
sterol plus a mevalonate-derived non-sterol metabolite,
possibly farnesyl pyrophosphate or farnesol. Four conserved phenylalanines in the sixth membrane span of the
transmembrane region are essential for degradation of
HMGRH [16]. Insig-1 also functions in the degradation of
HMGRH [17]: when cholesterol levels are high, SCAP and
HMGRH compete for binding to Insig-1. If SCAP binds Insig-1,
the SCAP-Insig-1 complex is retained in the Golgi, whereas if
HMGRH binds Insig-1, HMGRH is ubiquinated on lysine 248
and is rapidly degraded through a ubiquitin-proteasome
mechanism [18].
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Kinetic analysis of point mutants of HMGRP and of HMGRH,
and inspection of the crystal structures of HMGRP and
HMGRH, has identified an aspartate, a glutamate, a histidine,
and a lysine that are likely to be important and have suggested
their probable roles in catalysis (Figure 4) [11].

Lovastatin

interactions

Stage 2: [Mevaldyl-CoA]  [Mevaldehyde] + CoA-SH

HMG-CoA

refereed research

Stage 1: HMG-CoA + NADPH + H+  [Mevaldyl-CoA] + NADP+

H

deposited research

with the (S)-HMG-CoA and (R)-mevalonate designations
referring to the stereochemistry of the substrate and
product (enzymatic reactions are stereospecific and the
(R)-HMG-CoA isomer is not a substrate for HMGR). This
three-stage reaction involves two reductive stages and the
formation of enzyme-bound mevaldyl-CoA and mevaldehyde
as probable intermediates:

O

reports

(S)-HMG-CoA + 2 NADPH + 2 H+  (R)-mevalonate + 2
NADP+ + CoA-SH.

COOH
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The reaction catalyzed by HMGR is:

HO

H
O

Enzyme mechanism

COOH

comment

HO

O

HMGRs of eukaryotes are localized to the endoplasmic
reticulum (ER), and are directed there by a short portion of
the amino-terminal domain (prokaryotic HMGRs are soluble
and cytoplasmic). In humans, the reaction catalyzed by
HMGR is the rate-limiting step in the synthesis of cholesterol,
which maintains membrane fluidity and serves as a precursor
for steroid hormones. In plants, a cytosolic HMG-CoA
reductase participates in the synthesis of sterols, which are
involved in plant development, certain sesquiterpenes, which
are important in plant defense mechanisms against herbivores,
and ubiquinone, which is critical for cellular protein turnover.
In plastids, however, these compounds are synthesized via
a pathway that does not involve mevalonate or HMGR [1].
Various plant HMGR isozymes function in fruit ripening and
in the response to environmental challenges such as attack by
pathogens. In yeast, either of the two ER-anchored HMGR
isozymes can provide the mevalonate needed for growth.
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Figure 4
Proposed reaction mechanism for HMGRP [7,18]. The side groups of the key catalytic residues, Lys267, Asp283, Glu83, and His381, are shown, and the
substrate and products are shown with R representing the HMG portion. The reaction follows three stages (see text for details). A basically similar
mechanism has been proposed for HMGRH [4].

The catalytic activity of the HMGRs of higher eukaryotes is
attenuated by phosphorylation of a single serine, which in
the case of HMGRH is at position 872 [19]. The location of
this serine - six residues from the catalytic histidine, a
spacing conserved in all higher eukaryote HMGRs - suggests that the phosphoserine may interfere with the ability
of this histidine to protonate the inhibitory CoAS- thioanion
that is released in stage 2 of the reaction mechanism. Alternatively, it may interfere with closure of the flap domain, a
carboxy-terminal region that is thought to close over the
active site to facilitate catalysis, a step thought to be
essential for formation of the active site [7]. Subsequent
dephosphorylation restores full catalytic activity. HMGR
kinase (also called AMP kinase) phosphorylates HMGR; the
primary phosphatase in vivo is thought to be protein
phosphatase 2A (PP2A), but both phosphatases 2A and 2B
can catalyze dephosphorylation of vertebrate HMGR in
vitro [20]. HMGRH activity therefore responds to hormonal
control through AMP levels and PP2A activity. Phosphorylation of serine 577 of A. thaliana HMGR isozyme 1 by a
plant HMGR kinase that does not require 5’-AMP attenuates
activity, and restoration of HMGR activity follows from
dephosphorylation [21]. As many plant genes encode a
putative target serine surrounded by an apparent AMP
kinase recognition motif, it is probable that most plant
HMGRs are regulated by phosphorylation. Yeast HMGR
activity is, however, unaffected by AMP kinase. The phosphorylation state of HMGR does not affect the rate at
which the protein is degraded.

Frontiers
Several basic unresolved questions concern how phosphorylation controls the catalytic activity of HMGRs; solution of
the structures of phosphorylated HMGRs should reveal
more of the precise mechanism. The protein kinases, phosphatases, and signal-transduction pathways that participate in
short-term regulation of HMGR activity are yet to be
elucidated. Finally, the physiological roles served by the
multiple ways in which HMGR is regulated require clarification. On the medical side, continuing intense competition
between drug companies for a share of the lucrative worldwide
market for hypercholesterolemic agents should result in new
statin drugs with modified pharmacodynamic and metabolic
properties that not only lower plasma cholesterol levels
more effectively but more importantly minimize undesirable
side effects.
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